|
Confirmatory trial of non-amputative digit preservation surgery in subungual melanoma: JCOG1602 (J-NAIL study). |
|
|
Honoraria - Bristol-Myers Squibb Japan; Chugai Pharma; Maruho; Mitsubishi Tanabe Pharma; MSD; Novartis; Ono Pharmaceutical |
Consulting or Advisory Role - MSD Oncology |
Travel, Accommodations, Expenses - Bristol-Myers Squibb |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Honoraria - Chugai Pharma; Taiho Pharmaceutical |
|
|
No Relationships to Disclose |
|
|
Honoraria - Bristol-Myers Squibb Japan; Chugai Pharma; Eisai; MSD; Novartis; Ono Pharmaceutical; Toray Industries |
Consulting or Advisory Role - MSD Oncology |
|
|
Honoraria - Bristol-Myers Squibb Japan; Novartis; Ono Pharmaceutical |
|
|
No Relationships to Disclose |
|
|
Honoraria - Bristol-Myers Squibb Japan; MSD; Novartis; Ono Pharmaceutical |
|
|
Honoraria - Bristol-Myers Squibb Japan; MSD; Novartis; Ono Pharmaceutical; Southern Wish; Taisho Toyama Pharma; Toray Industries |
|
|
Honoraria - Bristol-Myers Squibb Japan; MSD; Novartis; Ono Pharmaceutical |
Consulting or Advisory Role - Bristol-Myers Squibb; MSD Oncology; Novartis; Ono Pharmaceutical |
Research Funding - Bristol-Myers Squibb; MSD; Novartis; Ono Pharmaceutical; Takara Bio |
Travel, Accommodations, Expenses - Novartis |